Identifying who is at risk of drug-induced liver injury: Is human leukocyte antigen specificity the key?-Reference-Cited by-同舟云学术

Identifying who is at risk of drug-induced liver injury: Is human leukocyte antigen specificity the key?

Published:2011-01 Issue:1 Volume:53 Page:358-362
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Chitturi Shivakumar,Farrell Geoffrey C.

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.24094/fullpdf

Reference21 articles.

1. Hepatotoxicity associated with non-steroidal anti-inflammatory drugs;Teoh;Clin Liver Dis,2003

2. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial;Schnitzer;Lancet,2004

3. Drug safety update: Lumiracoxib hepatotoxicity http://www.mhra.gov.uk/home/idcplg?IdcService=GET_FILE&dDocName=CON2033077&RevisionSelectionMethod=LatestReleased. 2010

4. Troglitazone-induced liver failure: a case study;Graham;Am J Med,2003

5. Halothane hepatitis. Detection of a constitutional susceptibility factor;Farrell;N Engl J Med,1985

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microphysiological Models for Mechanistic-Based Prediction of Idiosyncratic DILI;Cells;2023-05-25

2. The changing epidemiology of liver diseases in the Asia–Pacific region;Nature Reviews Gastroenterology & Hepatology;2018-08-29

3. The pharmacokinetics and metabolism of lumiracoxib in chimeric humanized and murinized FRG mice;Biochemical Pharmacology;2017-07

4. Hepatotoxicity induced by coxibs: how concerned should we be?;Expert Opinion on Drug Safety;2016-08-26

5. HLA-DQ B1*0201 and A1*0102 Alleles Are Not Responsible for Antituberculosis Drug-Induced Hepatotoxicity Risk in Spanish Population;Frontiers in Medicine;2016-08-22